Exasol (EXL) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
7 May, 2026Executive summary
Q1 2026 revenue was €9.5 million, down from €12.4 million in Q1 2025, mainly due to the absence of a one-time deal and non-recurring revenue items in the prior year.
Annual Recurring Revenue (ARR) declined 3.5% year-over-year to €37.8 million, but improved from -8.5% in Q4 2025, with reduced churn and retention of larger customers.
EBITDA for Q1 2026 was €0.4 million, down from €1.3 million in Q1 2025, impacted by higher marketing spend and lower non-recurring revenue.
Net liquid funds increased to €24.7 million at quarter-end, up from €18.7 million year-over-year, providing significant operational flexibility.
Guidance for FY2026 is confirmed, with expectations for ARR growth in the second half of the year.
Financial highlights
FY 2025 audited revenue was €41.8 million, up from €39.6 million in FY 2024; recurring revenue declined to €37.7 million from €39.1 million.
Non-recurring revenue in FY 2025 was €4.1 million, a significant increase from €0.5 million in FY 2024.
Gross profit margin for FY 2025 was 92%, down from 100% in FY 2024.
FY 2025 EBITDA was €4.1 million (9.7% margin), up from €2.0 million (5.1% margin) in FY 2024.
FY 2025 net income was €3.0 million, up from €0.2 million in FY 2024.
Outlook and guidance
2026 guidance confirmed: mid-single-digit percentage ARR growth, EBITDA between €3 million and €4 million, and revenue expected to decline in the mid-single-digit percentage range.
ARR churn rate expected to drop to approximately 10% for FY 2026, down from over 20% in 2025.
Foundation laid for ARR growth in the second half of 2026.
Capital market day scheduled for October 15 to provide a deeper dive into strategy.
Latest events from Exasol
- 2025 saw robust growth, AI integration, and improved profitability, with ARR set to rise in 2026.EXL
Q4 202519 Mar 2026 - EBITDA and net income surged, with focus industries driving ARR growth despite overall ARR decline.EXL
Q4 2025 TU3 Feb 2026 - First positive EBITDA since IPO, 12% ARR growth, and strong cash position in H1 2024.EXL
H1 20241 Feb 2026 - Positive EBITDA and double-digit growth achieved, with focus on regulated, hybrid markets.EXL
Q3 2024 TU14 Jan 2026 - Q1 2025 revenue and profitability surged, with focus verticals driving growth amid ARR decline.EXL
Q1 2025 TU26 Nov 2025 - Revenue up 10.8%, profitability rose, and focus verticals now drive 69% of ARR.EXL
Q2 202523 Nov 2025 - Revenue and EBITDA up, ARR down 4.1%; focus verticals and MariaDB to drive 2026 growth.EXL
Q3 2025 TU12 Nov 2025 - ARR fell 4.1% on high churn, but focus verticals and partnerships set up for 2026 growth.EXL
Trading Update27 Oct 2025 - First full-year profit since IPO, with double-digit revenue growth and improved outlook.EXL
H2 20249 Jun 2025